HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005
Clinical trial NCT04566445 · TERMINATED
Trial details
- NCT number
- NCT04566445
- Sponsor
- Gyroscope Therapeutics Limited
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-28
- Primary completion
- 2024-06-10
- Enrollment
- 255
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.